Massachusetts Financial Services Co. MA Has $286.82 Million Position in Masimo Co. (NASDAQ:MASI)

Massachusetts Financial Services Co. MA boosted its stake in Masimo Co. (NASDAQ:MASI - Free Report) by 119.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,735,167 shares of the medical equipment provider's stock after buying an additional 943,001 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 3.24% of Masimo worth $286,823,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of MASI. Jones Financial Companies Lllp bought a new stake in shares of Masimo during the fourth quarter worth $27,000. UMB Bank n.a. grew its holdings in Masimo by 180.9% during the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock worth $32,000 after acquiring an additional 123 shares during the last quarter. Blue Trust Inc. grew its stake in shares of Masimo by 56.3% during the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock valued at $33,000 after purchasing an additional 71 shares during the last quarter. Trust Co. of Vermont bought a new position in Masimo in the 4th quarter valued at $33,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Masimo by 40.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock valued at $37,000 after buying an additional 64 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Trading Up 13.4 %

Shares of MASI stock traded up $19.51 on Wednesday, reaching $164.57. The company had a trading volume of 1,465,849 shares, compared to its average volume of 651,117. The company has a 50-day moving average of $171.45 and a 200-day moving average of $163.95. Masimo Co. has a 12 month low of $101.61 and a 12 month high of $194.88. The stock has a market cap of $8.89 billion, a PE ratio of 113.50 and a beta of 1.28. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50.

Remove Ads

Masimo (NASDAQ:MASI - Get Free Report) last posted its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The company had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. On average, equities analysts forecast that Masimo Co. will post 4.1 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MASI shares. Raymond James raised their price target on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a report on Friday, December 27th. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a research note on Wednesday, February 26th. Wells Fargo & Company boosted their price target on shares of Masimo from $193.00 to $205.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, Piper Sandler increased their price objective on shares of Masimo from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $194.80.

Insider Transactions at Masimo

In related news, Director Craig B. Reynolds sold 2,053 shares of Masimo stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the sale, the director now owns 16,581 shares of the company's stock, valued at approximately $2,754,601.53. The trade was a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the company's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the completion of the sale, the chief operating officer now directly owns 24,172 shares in the company, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 9.70% of the stock is currently owned by insiders.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.